Zobrazeno 1 - 10
of 164
pro vyhledávání: '"Obesity medication"'
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 28, Iss 5, Pp 445-460 (2024)
Obesity is a heterogeneous, complex, and chronic disease that has a detrimental impact on disability-adjusted life years across the globe. Recent advancements in our understanding of gut-brain communication at the molecular level have driven the deve
Externí odkaz:
https://doaj.org/article/d4c675bfdb2e4eedbe3fa93993eac790
Publikováno v:
Diabetology, Vol 5, Iss 3, Pp 234-245 (2024)
The prevalence of obesity in adults with type 1 diabetes is increasing and reflects the rates of the general adult population. The coexistence of overweight or obesity and type 1 diabetes poses a major challenge to effective glycemic and weight manag
Externí odkaz:
https://doaj.org/article/69e29db473ed400fa9e56e2d64041b78
Autor:
Hae Woon Jung
Publikováno v:
Precision and Future Medicine, Vol 8, Iss 2, Pp 38-49 (2024)
Obesity is pervasive from infancy to adulthood and presents a major challenge to healthcare systems worldwide. In children and adolescents, the prevalence of overweight and obesity continues to increase, especially in classes II and III, and in young
Externí odkaz:
https://doaj.org/article/1aefd55d9e724d639cf5a60dfc41a59a
Autor:
Treah Haggerty, Patricia Dekeseredy, Joanna Bailey, Abigail Cowher, Adam Baus, Laura Davisson
Publikováno v:
Obesity Pillars, Vol 11, Iss , Pp 100120- (2024)
Introduction: Obesity rates continue to rise in the United States. Treatment includes modification of diet, exercise, behavioral modification and medical consideration including anti-obesity medications. However, multiple highly effective anti-obesit
Externí odkaz:
https://doaj.org/article/4257fc263ebc4ee991651c51af1b161b
Autor:
Sherri L. LaVela, Kelsey Berryman, Ibuola Kale, Gary J. Farkas, Geoffrey V. Henderson, Vanessa Rosales, Dan Eisenberg, Lorena Reyes
Publikováno v:
Obesity Science & Practice, Vol 10, Iss 4, Pp n/a-n/a (2024)
Abstract Background Anti‐obesity medications (AOMs) may provide a viable option for obesity management. However, little is known about the use of AOMs in persons with SCI/D. Objective Describe health care providers' (HCPs) views about barriers to A
Externí odkaz:
https://doaj.org/article/642b887778be4e648e52311bf24a3da5
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 7 (2024)
Externí odkaz:
https://doaj.org/article/1623ca576d264796a4957219e2fcc879
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 18, Pp 845-858 (2024)
Ji-Eun Song,1 Hae-Jin Ko,2 A-Sol Kim1 1Department of Family Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Korea; 2Department of Family Medicine, School of Medicine, Kyungpook Natio
Externí odkaz:
https://doaj.org/article/38d052a65bfa4ab59950ea7231558f32
Autor:
Gunther Wong, Erica M. Garner, Sahar Takkouche, Matthew D. Spann, Wayne J. English, Vance L. Albaugh, Gitanjali Srivastava
Publikováno v:
Obesity Science & Practice, Vol 9, Iss 3, Pp 203-209 (2023)
Abstract Background Combination anti‐obesity medications (AOMs) to treat postoperative bariatric surgery weight regain have limited data on their use in the clinical setting. Understanding the optimal treatment protocol in this cohort will maximize
Externí odkaz:
https://doaj.org/article/56e9e0c8cea444dfba17da7c9a19055d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the Pakistan Medical Association, Vol 73, Iss 05 (2023)
This communication uses the quincunx, i.e, a quadruple surrounding a central point, to create a model that describes the etiopathogenesis, as well as informs the management strategy of obesity. With the energy fulcrum (mismatch between energy inta
Externí odkaz:
https://doaj.org/article/ea2949758f20488884c33a2f6a50f1b7